Daiwa Securities Group
APGE icon

Daiwa Securities Group’s Apogee Therapeutics APGE Stock Holding History

Daiwa Securities Group’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-166
Closed -$13K – 1201
2025
Q4 		$13K Hold
166
– – ﹤0.01% 1169
2025
Q3 		$7K Hold
166
– – ﹤0.01% 1177
2025
Q2 		$7K Buy
166
+35
+27% +$1.33K ﹤0.01% 1130
2025
Q1 		$5K Sell
131
-40
-23% -$1.55K ﹤0.01% 1127
2024
Q4 		$8K Hold
171
– – ﹤0.01% 1130
2024
Q3 		$10K Buy
171
+34
+25% +$1.63K ﹤0.01% 1128
2024
Q2 		$5K Hold
137
– – ﹤0.01% 1194
2024
Q1 		$9K Sell
137
-59
-30% -$2.58K ﹤0.01% 1169
2023
Q4 		$5K Buy
+196
New +$3.93K ﹤0.01% 1200

Other funds holding APGE

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return